Isolated polycystic liver disease.
Isolated polycystic liver disease (PCLD) is an autosomal dominant disease with genetic and clinical heterogeneity. Apart from liver cysts, it exhibits few extrahepatic manifestations, and the majority of patients with this condition are asymptomatic or subclinical. However, a small fraction of these patients develop acute liver cyst-related complications and/or massive cystic liver enlargement, causing morbidity and mortality. Currently, the management for symptomatic PCLD is centered on palliating symptoms and treating complications.
Qian
Qi
Q
Mayo Clinic College of Medicine, Rochester, MN 55905, USA. qian.qi@mayo.edu
D003937:Diagnosis, Differential; D006801:Humans; D007668:Kidney / Q000473:pathology*; D008107:Liver Diseases / Q000401:mortality / Q000473:pathology / Q000628:therapy; D009017:Morbidity; D016891:Polycystic Kidney, Autosomal Dominant / Q000401:mortality / Q000473:pathology / Q000628:therapy